Patients suffering from breast cancer in which the lymph nodes are already affected usually receive prophylactic chemotherapy which sometimes entails many side effects. Scientists at the Comprehensive Cancer Center Vienna (CCC), a joint establishment of the MedUni Vienna and the Vienna General Hospital, demonstrate in a current study that the risk of metastasis can be measured with a new multi-gene test. Patients, who are not at risk, can in future – the test is not yet carried out routinely – be spared this gruelling treatment.
↧